Advanced search
Companies (7)
The Marcus Corporation is engaged in the lodging and entertainment industries, with significant the Company-owned real estate assets. The Companyâs theatre division, Marcus Theatres, is a theater circuit in the United States. Marcus Theatres owns or ope ...
Capitalization | 334 M USD |
---|---|
Change | +0.68% |
1-year price change | -28.67% |
iWallet Corporation is focused on designing and developing biometric locking wallets and related physical and personal security products that incorporate security and communication technologies to protect against identity, personal and financial informati ...
Capitalization | 2 M USD |
---|---|
Change | +8.70% |
1-year price change | +42.86% |
Dream Residential Real Estate Investment Trust (the REIT) is a Canada-based unincorporated, open-ended real estate investment trust. The REIT owns a portfolio of garden-style multi-residential properties, primarily located in three markets across the Sunb ...
Capitalization | 75 M USD |
---|---|
Change | -4.21% |
1-year price change | +2.25% |
Marcus & Millichap, Inc. is a brokerage company. The Company is specialized in commercial real estate investment sales, financing services, research, and advisory services. The Company also offers market research, consulting, and advisory services to its ...
Capitalization | 1 182 M USD |
---|---|
Change | -1.36% |
1-year price change | -30.01% |
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of novel therapeutics for a range of cancer indications. The Company's product candidates, galinpepimut-S (GPS), a peptide immun ...
Capitalization | 84 M USD |
---|---|
Change | -1.36% |
1-year price change | +36.79% |
MCOT Public Company Limited is a Thailand-based company engaged in the mass media business. It is a state enterprise under the supervision of the Office of the Prime Minister. The Company's services include television and news services, radio services, en ...
Capitalization | 54 M USD |
---|---|
Change | -3.36% |
1-year price change | -9.43% |
AngioGenex, Inc. is a biopharmaceutical company, which is engaged in discovering and development of Id protein inhibitors to address unmet medical needs in oncology and ophthalmology. The Company and its collaborators, including Robert Benezra, Ph.D. and ...
Capitalization | - USD |
---|---|
Change | -.--% |
1-year price change | -99.85% |
- Stock Market
- Advanced search
- Marcus A. Ketter
- Company Profiles